1. Home
  2. HOLX

as of 02-25-2026 4:00pm EST

$75.34
$0.01
-0.01%
Stocks Health Care Medical Electronics Nasdaq

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Founded: 1985 Country:
United States
United States
Employees: N/A City: MARLBOROUGH
Market Cap: 16.6B IPO Year: 1995
Target Price: $77.89 AVG Volume (30 days): 2.5M
Analyst Decision: Hold Number of Analysts: 13
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.79 EPS Growth: -25.00
52 Week Low/High: $51.90 - $75.48 Next Earning Date: 04-27-2026
Revenue: $4,100,500,000 Revenue Growth: 1.74%
Revenue Growth (this year): 4.74% Revenue Growth (next year): 5.03%
P/E Ratio: 95.38 Index:
Free Cash Flow: 998.3M FCF Growth: -15.34%

AI-Powered HOLX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.19%
70.19%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Hologic Inc. News

HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing

All HOLX News

Share on Social Networks: